| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |